Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hematopoietic Stem Cell Mobilization”

197 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 197 results

Testing effectiveness (Phase 2)Study completedNCT01105403
What this trial is testing

Exploratory Study on POL6326 in Stem Cell Mobilization

Who this might be right for
Multiple Myeloma
Polyphor Ltd. 21
Not applicableUnknownNCT04960761
What this trial is testing

The Effectiveness of the Training Given With Audio and Picture Book Before the Surgery

Who this might be right for
Pediatric ALLAppendix Diseases
Saglik Bilimleri Universitesi 70
Testing effectiveness (Phase 2)Study completedNCT00322842
What this trial is testing

Treatment With AMD3100 (Plerixafor) in Non-Hodgkin's Lymphoma and Multiple Myeloma Patients

Who this might be right for
Lymphoma, Non-HodgkinMultiple Myeloma
Genzyme, a Sanofi Company 35
Testing effectiveness (Phase 2)Study completedNCT01753453
What this trial is testing

An Exploratory Safety Study to Investigate the Extent of Tumor Cell Mobilization (TCM) After Use of G-CSF Alone or G-CSF Plus Plerixafor in Multiple Myeloma (MM) Patients Who May be Poor Mobilizers of Stem Cells

Who this might be right for
Multiple Myeloma
Sanofi 23
Not applicableUnknownNCT02184897
What this trial is testing

Pharmacokinetic and Pharmacodynamic Study of Lenograstim for Hematopoietic Stem Cell Mobilization

Who this might be right for
Multiple Myeloma
Asan Medical Center 24
Not applicableStudy completedNCT00001071
What this trial is testing

Stem Cells and Filgrastim

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 24
Testing effectiveness (Phase 2)Study completedNCT00306111
What this trial is testing

Pegfilgrastim vs. Filgrastim - Comparison of Mobilized Blood Stem Cells in Patients With Non Hodgkin-lymphoma

Who this might be right for
Non-Hodgkin Lymphoma
University Hospital Tuebingen 14
Large-scale testing (Phase 3)Study completedNCT02288741
What this trial is testing

Tandem Melphalan and Autolog. SCT in MM Patients 60 to 70 Years of Age With and Without Induction Chemotherapy

Who this might be right for
Multiple Myeloma
WiSP Wissenschaftlicher Service Pharma GmbH 549
Testing effectiveness (Phase 2)UnknownNCT03014102
What this trial is testing

Recombinant Human Thrombopoietin for Mobilization of Peripheral Blood Progenitor Cells for Autologous Transplantation

Who this might be right for
ThrombocytopoietinHematopoietic Stem Cell MobilizationHematopoietic Stem Cell Transplantation
Hongnan Mo 50
Testing effectiveness (Phase 2)Study completedNCT01225419
What this trial is testing

Mobilization by Plerixafor of Haematopoietic Stem Cells in Children

Who this might be right for
Children Cancer, Solid Tumor
University Hospital, Clermont-Ferrand 5
Early research (Phase 1)Study completedNCT02073019
What this trial is testing

A Phase I Study Evaluating Safety, Tolerability, PK and PD of BL-8040 for Stem Cell Mobilization in Healthy Volunteers

Who this might be right for
Mobilization of Hematopoietic Stem Cells (HSC) to Peripheral Blood (PB)
BioLineRx, Ltd. 33
Large-scale testing (Phase 3)Study completedNCT01767714
What this trial is testing

Evaluation of Plerixafor Plus G-CSF to Mobilize and Collect 5×10^6CD34+ Cells/kg in Non-Hodgkin's Lymphoma (NHL) Patients for Autologous Transplantation

Who this might be right for
Non-Hodgkin's Lymphoma
Sanofi 100
Large-scale testing (Phase 3)Ended earlyNCT01301963
What this trial is testing

Filgrastim With or Without Plerixafor in Treating Patients With Multiple Myeloma Previously Treated With Lenalidomide

Who this might be right for
Refractory Multiple Myeloma
Case Comprehensive Cancer Center 9
Testing effectiveness (Phase 2)Study completedNCT00011505
What this trial is testing

Mobilization of Stem Cells With G-CSF for Collection From Patients With Diamond-Blackfan Anemia

Who this might be right for
Diamond Blackfan Anemia
National Heart, Lung, and Blood Institute (NHLBI) 15
Testing effectiveness (Phase 2)Study completedNCT01696461
What this trial is testing

A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor

Who this might be right for
Related Donors Donating Peripheral Blood Stem Cells (PBSC) to a Family MemberAcute Myelogenous LeukemiaAcute Lymphoblastic Leukemia+5 more
Center for International Blood and Marrow Transplant Research 127
Testing effectiveness (Phase 2)Study completedNCT00322491
What this trial is testing

Mobilization of Stem Cells With AMD3100 (Plerixafor) and G-CSF in Non-Hodgkin's Lymphoma and Multiple Myeloma Patients

Who this might be right for
Lymphoma, Non-HodgkinMultiple Myeloma
Genzyme, a Sanofi Company 49
Early research (Phase 1)Study completedNCT01074060
What this trial is testing

Plerixafor and Filgrastim Following Cyclophosphamide for Stem Cell Mobilization in Patients With Multiple Myeloma

Who this might be right for
Refractory Multiple MyelomaStage I Multiple MyelomaStage II Multiple Myeloma+1 more
City of Hope Medical Center 18
Testing effectiveness (Phase 2)Study completedNCT02639559
What this trial is testing

Safety and Efficacy of BL-8040 for the Mobilization of Donor Hematopoietic Stem Cells and Allogeneic Transplantation in Patients With Advanced Hematological Malignancies

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphoblastic LeukemiaChronic Myelogenous Leukemia+8 more
Washington University School of Medicine 50
Testing effectiveness (Phase 2)UnknownNCT00984178
What this trial is testing

Trial of Hematopoietic Stem Cells in Acute Myocardial Infarction

Who this might be right for
Reperfused Acute Myocardial Infarction
TECAM Group 120
Early research (Phase 1)Study completedNCT00001748
What this trial is testing

HLA-Mismatched Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematological Malignancies

Who this might be right for
Graft vs Host DiseaseHematologic NeoplasmsLymphoma+2 more
National Heart, Lung, and Blood Institute (NHLBI) 35
Next Page